| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |